hta_admin | Health Technology Assessment Division

[Department Personnel No. 2022- 2780 – A] Amendment to the Department Personnel Order No. 2021-2780 Entitled “Creation of the Pool of Clinical Experts for Consultation on the Evaluation of Assessment Topics” to Include Expert Advisory Committee as Additional Experts

Posted on May 17, 2022

SOH Decision: Tocilizumab for the Treatment of COVID-19

Posted on May 11, 2022

Return to Main Page SOH approves the HTAC recommendation on tocilizumab for COVID-19 in the Philippine National Formulary (PNF) The Secretary of Health (SOH) approved the HTAC recommendation on the addition of tocilizumab for COVID-19 in the Philippine National Formulary (PNF) on 11 May 2022. On 15 March 2022, the Philippine FDA issued the CPR of tocilizumab continue reading : SOH Decision: Tocilizumab for the Treatment of COVID-19

[Department Personnel Order No. 2022- 1245] Appointment of the New Member of the Health Technology Assessment Council Subcommittee on Drugs

Posted on May 10, 2022

Preliminary Recommendation for the Inclusion of Potassium Citrate 1620 mg (15 mEq) Tablet in the PNF

Posted on April 13, 2022

Document link: HTAC Preliminary Recommendation of Potassium Citrate 15mEq Tablet (Proponents may submit appeals to hta@doh.gov.ph until 27 April 2022.) Document Preview:

[Department Personnel Order No. 2022- 1102] Authority for Select Department of Health (DOH) Personnel to conduct a Hybrid Workshop on the Development of Guidelines in the Creation of the Philippine Essential Medical Device List (PEMDL) on April 22, 2022 in Metro Manila,

Posted on April 7, 2022